Contributor Page
Ashurst
 
Email  |  Articles
Contact Details
Tel: +49 69 971126
Fax: +49 69 97205220
Oberlindau 76-78
Frankfurt
60323
Germany
By Richard Best
It is well known that the Freedom of Information Act 2000's right of access to information held by public authorities came into force on 1 January 2005. It is also known that commercial entities dealing with or otherwise providing information to public authorities could be affected by the changes.
By Richard Best
The Freedom of Information Act 2000 ("FOIA") gives people access to information held by public authorities which in many instances they could not previously access. Blogging gives people a publishing power they did not previously have. From commercial and legal perspectives, their combination may make for a potentially dangerous mix.
By Richard Best
This article provides an update on the issue of whether a public authority is permitted to make a copy of documents, otherwise protected by copyright, when responding to a request for information under the Freedom of Information Act 2000 ("FOIA"), whose right of access to information held by public authorities comes into force in January 2005.
The Freedom of Information Act ("FOIA") was enacted in November 2000. However, its most important provision - the personal right of access to information held by public authorities - does not come into force until January 2005. When that day comes the current non-statutory rules on access to publicly held information, contained in the Code of Practice on Access to Government Information, will be replaced by a far-reaching and comprehensive statutory regime.
In the United Kingdom as in other countries, pharmaceutical companies, among others, have had their premises raided by regulators such as the Serious Fraud Office and competition and fair trade authorities.
Pharmaceutical companies produce a wealth of valuable and commercially sensitive information, much of which needs to be kept beyond competitors' reach. Nevertheless, a measure of disclosure is commonplace given the data and fairness requirements of regulators, codes on access to government information or freedom of information legislation, and the disclosure process in civil proceedings if a company finds itself in court.
By Richard Best, Richard Best
The House of Commons Select Committee on Health's recent Report on the National Institute for Clinical Excellence